Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Adriana Ceci, Rosa Conte, Antonella Didio, Donato Bonifazi, Mariagrazia Felisi, Viviana Giannuzzi & Fedele Bonifazi. (2019) An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload. Expert Opinion on Orphan Drugs 7:4, pages 181-197.
Read now
Read now
Mable Misha Singh, Ravindra Kumar, Satyendra Tewari & Sarita Agarwal. (2019) Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients. Hematology 24:1, pages 20-25.
Read now
Read now
Galila M. Mokhtar, Eman M. Sherif, Nevin M. Habeeb, Abeer A. Abdelmaksoud, Eman A. El-Ghoroury, Ahmed S. Ibrahim & Enas M. Hamed. (2016) Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major. Hematology 21:1, pages 46-53.
Read now
Read now
Wing-Yan Au, Chun Fu Li, Jian Pei Fang, Guang Fu Chen, Xin Sun, Chang Gang Li, Xin Hua Zhang, Xue Dong Wu, Hong Ying Gao, Wen Ge Hao, Darshana Rasalkar, Min Deng, Sio Peng A. Mok, Fernando Tricta & Winnie C.W. Chu. (2014) Assessment of Iron Overload in Very Young Children with Limited Thalassemia Care Resources in South China. Hemoglobin 38:2, pages 119-126.
Read now
Read now
Annita Kolnagou, Konstantinos Natsiopoulos, Marios Kleanthous, Alexia Ioannou & George J. Kontoghiorghes. (2013) Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*. Toxicology Mechanisms and Methods 23:1, pages 48-56.
Read now
Read now
Dimitrios Tsiapras, Soso Fragatou, Kalistheni Farmaki, Stamatios Kyrzopoulos, Ioannis Paraskevaidis, Vasilios Voudris & Dimitrios Kremastinos. (2010) Effect of Combined Chelation Therapy with Deferiprone and Deferoxamine on Left Ventricular Diastolic Function in Adult β-Thalassemia Major Patients. Hemoglobin 34:3, pages 210-220.
Read now
Read now
Ching-Tien Peng, Jeng-Sheng Chang, Lin-Yen Wang, Shyh-Shin Chiou, Chih-Cheng Hsiao, Shih-Chung Wang, Giun-Yi Hung & Kang-Hsi Wu. (2009) Update on Thalassemia Treatment in Taiwan, Including Bone Marrow Transplantation, Chelation Therapy, and Cardiomyopathy Treatment Effects. Hemoglobin 33:5, pages 304-311.
Read now
Read now
Ching-Tien Peng, Chang-Hai Tsai & Kang-Hsi Wu. (2008) Effects of Chelation Therapy on Cardiac Function Improvement in Thalassemia Patients: Literature Review and the Taiwanese Experience. Hemoglobin 32:1-2, pages 49-62.
Read now
Read now
Articles from other publishers (10)
Latika Puri, Jonathan M. Flanagan, Guolian Kang, Juan Ding, Wenjian Bi, Beth M. McCarville, Ralf B. Loeffler, Aaryani Tipirneni-Sajja, Martha Villavicencio, Kristine R. Crews, Claudia M. Hillenbrand & Jane S. Hankins. (2019) GSTM1 and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload. Journal of Clinical Medicine 8:11, pages 1878.
Crossref
Crossref
Ivan Chakarov, Tatyana Vlaykova, Emil Slavov, Rumen Marinov & Petrana Chakarova. (2013) Role of serum pro-hepcidin and GSTM1 and GSTT1 null polymorphisms for estimation of the risk of myocardial siderosis in children and “young adults” with β-thalassemia major. Comparative Clinical Pathology 23:3, pages 725-733.
Crossref
Crossref
Dudley J. Pennell, James E. Udelson, Andrew E. Arai, Biykem Bozkurt, Alan R. Cohen, Renzo Galanello, Timothy M. Hoffman, Michael S. Kiernan, Stamatios Lerakis, Antonio Piga, John B. Porter, John Malcolm Walker & John Wood. (2013) Cardiovascular Function and Treatment in β-Thalassemia Major. Circulation 128:3, pages 281-308.
Crossref
Crossref
M. ‐Y. Lu, S. S. F. Peng, H. ‐H. Chang, Y. ‐L. Yang, C. ‐A. Chen, S. ‐T. Jou, D. ‐T. Lin & K. ‐H. Lin. (2013) Cardiac iron measurement and iron chelation therapy in patients with β thalassaemia major: experience from Taiwan. Transfusion Medicine 23:2, pages 100-107.
Crossref
Crossref
Jingwen Zhang, Hu Liu, Hongyi Yan, Guoliang Huang & Bin Wang. (2013) Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: A meta-analysis. Gene 518:2, pages 405-411.
Crossref
Crossref
Vineeta Sharma, Bijender Kumar & Renu Saxena. (2009) Glutathione S-transferase gene deletions and their effect on iron status in HbE/β thalassemia patients. Annals of Hematology 89:4, pages 411-414.
Crossref
Crossref
Jonathan M. Flanagan, Shirley Steward, Jane S. Hankins, Thad M. Howard, Geoffrey Neale & Russell E. Ware. (2009) Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta‐thalassemia. American Journal of Hematology 84:6, pages 328-334.
Crossref
Crossref
Leila J. NoetzliSusan M. Carson, Anne S. Nord, Thomas D. Coates & John C. Wood. (2008) Longitudinal analysis of heart and liver iron in thalassemia major. Blood 112:7, pages 2973-2978.
Crossref
Crossref
R. Origa, S. Satta, G. Matta & R. Galanello. (2008) Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassaemia major. British Journal of Haematology 142:1, pages 143-145.
Crossref
Crossref
Athanassios Aessopos, Vasilios Berdoukas & Maria Tsironi. (2007) The heart in transfusion dependent homozygous thalassaemia today - prediction, prevention and management. European Journal of Haematology 80:2, pages 93-106.
Crossref
Crossref